RegenLab USA Moves to Jersey City

On Jan 2, 2024

JLL announced that it has arranged a long-term lease for RegenLab USA at 95 Greene St., the new lab-ready life sciences property developed by Thor Equities Group in Jersey City.

RegenLab USA, which manufactures devices for the production of regenerative cell therapy, will relocate from the Brooklyn Army Terminal in New York to occupy 15,792 square feet across the sixth floor of the recently completed property in the second quarter of 2024. The company will use the space for office, research and manufacturing of medical devices and platelet rich plasma products.

“We are pleased to welcome RegenLab to 95 Greene Street and are confident their talented team will thrive in their new state-of-the-art headquarters. Ideally located in one of the leading life science markets in the country, 95 Greene offers a range of amenities, unmatched access to talent, and central location just minutes from Manhattan,” said Melissa Gliatta, COO of Thor Equities.

“We are thrilled to welcome RegenLab USA to New Jersey,” said Wes Mathews, President and CEO of Choose New Jersey. “With the growth and expansion of the 95 Greene life sciences hub in Jersey City, RegenLab will benefit from the twin pillars of our state’s value proposition: having the nation’s most talented workforce, and an unbeatable location. With this announcement, Jersey City is well-positioned to be a continued leader in the life sciences industry.”

Originally built as a manufacturing plant for Colgate Palmolive, 95 Greene St. is an eight-story, 350,000-square-foot property redeveloped by Thor to meet surging demand from life science companies seeking custom space in well-located markets.

The property offers abundant power resources served by multiple utility grids, 13- to 15-foot ceiling heights, secured interior loading docks, an on-site life-safety generator and flexible floor plates. Onsite underground parking is available for 125 vehicles. Thor worked with SGA Architects to complete the comprehensive adaptive reuse project, which included extensive upgrades to mechanicals, HVAC, vertical conduits and a new rooftop generator.

JLL Senior Managing Director Dan Spero, Managing Director Blake Goodman, Senior Vice Presidents John Cahill and Bob Ryan and Executive Vice President Craig Eisenhardt serve as exclusive agents for 95 Greene St. and represented Thor Equities Group and RegenLab in the lease negotiations.

RegenLab is the latest tenant to relocate from New York City to 95 Greene St. in the past 18 months. To date, the JLL team has arranged approximately 75,000 square feet of new leases with tenants including Jersey City Medical Center and cellular agriculture company Fork & Good, Inc.

“We are seeing significant activity from companies like RegenLab seeking to relocate from New York to best-in-class properties highly accessible to a skilled labor pool,” said Goodman. “95 Greene offers a powerful destination given its proximity to both NYC and NJ talent with great transit access from both sides.”

To access more business news, visit NJB News Now.

Related Articles: